Enter your login e-mail to the account
Search
Search parameters
Search results
- Antiobesity drugs in the management of obese type 2 diabetic patients
MUDr. Ľubomíra Fábryová, PhD.
(5/2020, Topic of the year ) - Victoza (liraglutid)
MUDr. Jitka Jurková
(4/2011, Drugs & drug classes ) - Antiatherogenic effect and cardiovascular benefit of GLP-1 receptor´s agonists
doc. MUDr. Štefan Farský, CSc., FESC
(4/2022, Drugs & drug classes ) - Pharmacological management of the patients living with obesity before and after bariatric/metabolic surgery
doc. MUDr. Ľubomíra Fábryová, PhD., MPH
(6/2024, Topic of the year ) - Relative safety of new obesity drugs: latest evidence and patient management
MUDr. Ľubomíra Fábryová, PhD.
(2/2017, Topic of the year ) - INCRETINS, INCRETIN EFFECT AND DIABETES MELLITUS
MUDr. Adriana Ilavská
(S4/2007, Supplement ) - GLP-1 receptor agonists in therapy of obesity
doc. MUDr. Zbynek Schroner, PhD.
(2/2022, Drugs & drug classes ) - News in pharmacological treatment of obesity/diabesity
doc. MUDr. Ľubomíra Fábryová, PhD., MPH
(5/2022, Topic of the year ) - Weight loss pharmacotherapy of obese non-diabetic and type 2 diabetic patients
MUDr. Ľubomíra Fábryová, PhD.
(6/2015, Topic of the year ) - INCRETIN-BASED THERAPY IN THE TREATMENT OF TYPE 2 DIABETES MELLITUS
MUDr. Zbynek Schroner, PhD., MUDr. Vladimír Uličiansky
(7-8/2008, Topic ) - WEIGHT MANAGEMENT FOR OBESE TYPE 2 DIABETICS
MUDr. Ľubomíra Fábryová, PhD.
(7-8/2008, Topic )
- Alzheimer’s disease and type 2 diabetes mellitus
doc. MUDr. Roman Jirák, CSc., doc. MUDr. Miroslav Zeman, CSc.
(2/2012, From the boundary of neurology )
- News in pharmacological treatment of obesity/diabesity
doc. MUDr. Ľubomíra Fábryová, PhD., MPH
(2/2023, Current pharmacotherapy ) - Victoza (liraglutid)
MUDr. Jitka Jurková
(3/2011, New medicinal substances )